Miyoshi Kentaroh, Oto Takahiro, Okazaki Mikio, Yamane Masaomi, Toyooka Shinichi, Goto Keiji, Sano Yoshifumi, Sano Shunji, Miyoshi Shinichiro
Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Ann Thorac Surg. 2009 Nov;88(5):e56-7. doi: 10.1016/j.athoracsur.2009.07.089.
A 21-year-old man with pulmonary fibrosis and a 27-year-old woman with idiopathic pulmonary hypertension, who were in pulmonary hypertensive crisis, were successfully treated by using venoarterial extracorporeal membrane oxygenation, followed by living-donor lobar lung transplantation. In both of the patients, bridging time of extracorporeal membrane oxygenation to lung transplantation was 2 days, and both could be weaned from cardiopulmonary support immediately after transplantation in the operating room. No major complications were seen, including primary graft dysfunction. The cardiopulmonary functions of these patients markedly improved after living-donor lobar lung transplantation.
一名患有肺纤维化的21岁男性和一名患有特发性肺动脉高压且处于肺动脉高压危象的27岁女性，通过静脉-动脉体外膜肺氧合治疗成功，随后接受了活体供体肺叶移植。两名患者体外膜肺氧合至肺移植的桥接时间均为2天，且均在手术室移植后立即脱离心肺支持。未出现包括原发性移植物功能障碍在内的重大并发症。这些患者在活体供体肺叶移植后心肺功能明显改善。
